RADNOR, Pa. -- Food retail and food service markets now have a powerful tool for fighting pathogens and spoilage organisms and for boosting the confidence of consumers and customers.
Sterilox Technologies Inc. has launched the A-2000, the first model in its compact line of generators designed specifically for the food industry. The entire line of Sterilox generators is designed to produce a safe, fast and effective biocide onsite, which works against a wide range of pathogens and organisms that present major safety and health challenges.
Produced from salt and water, Sterilox is safe -- the solution is pH neutral, non-toxic, virtually odorless and tasteless, and is an environmentally friendly oxidant. Using patented electrolytic technology, the A-2000 unit generates Sterilox on demand, eliminating concerns about shelf stability or chemical storage.
Sterilox solutions are effective in a variety of food retail and service uses. Sterilox reduces spoilage organisms associated with fruits, vegetables, seafood and cut flowers. In addition, Sterilox is a hard-surface sanitizer for counter tops, slicers, cutting boards and utensils. The product may also be used in produce misting systems and ice machines to remove bio- films associated with harmful bacteria, such as the organism that causes Legionnaires' disease. Sterilox has been determined suitable for food processing applications by the FDA and has passed EPA surface sanitizer testing requirements.
Generators produce the product on site, on demand, and come in a variety of sizes for commercial application. The A-2000 food model is 2 feet wide and less than 3 feet deep and fits under most sinks, saving valuable floor space.
Sterilox Technologies, Inc. is a leading developer and marketer of sterilization and disinfection generators, and their solutions are based on the proprietary electrochemical activation of dilute brine solutions.
Source: Sterilox Technologies, Inc.
The Next Frontier in Infection Control: AI-Driven Operating Rooms
Published: July 15th 2025 | Updated: July 15th 2025Discover how AI-powered sensors, smart surveillance, and advanced analytics are revolutionizing infection prevention in the OR. Herman DeBoard, PhD, discusses how these technologies safeguard sterile fields, reduce SSIs, and help hospitals balance operational efficiency with patient safety.
Targeting Uncertainty: Why Pregnancy May Be the Best Time to Build Vaccine Confidence
July 15th 2025New national survey data reveal high uncertainty among pregnant individuals—especially first-time parents—about vaccinating their future children, underscoring the value of proactive engagement to strengthen infection prevention.
CDC Urges Vigilance: New Recommendations for Monitoring and Testing H5N1 Exposures
July 11th 2025With avian influenza A(H5N1) infections surfacing in both animals and humans, the CDC has issued updated guidance calling for aggressive monitoring and targeted testing to contain the virus and protect public health.
IP LifeLine: Layoffs and the Evolving Job Market Landscape for Infection Preventionists
July 11th 2025Infection preventionists, once hailed as indispensable during the pandemic, now face a sobering reality: budget pressures, hiring freezes, and layoffs are reshaping the field, leaving many IPs worried about their future and questioning their value within health care organizations.